Trial Search Results

Use of PET/MR Imaging in Chronic Pain

The investigators are studying the ability of PET/MR imaging (using the PET tracer [18F]FDG) to objectively identify and characterize pain generators in patients suffering from chronic pain.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: GE Healthcare


  • Drug: [18F]FDG
  • Device: PET/MRI


Phase 1


Inclusion Criteria:

   - Age 18 years or older.

   - Chronic pain lasting greater than 2 months. For example: Low back pain, sciatica,
   complex regional pain syndrome, peripheral nerve injury, fibromyalgia, neuropathy,
   osteoarthritis, cancer pain, persistent post-operative pain, and migraine.

   - Provides informed consent

   - On a typical day, pain level of at least 4/10 on a 0-10 Comparative Pain Scale

   - Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative
   test result from the Covid test within 72 hours of the scan.

Exclusion Criteria:

   - MRI-incompatible

   - Diabetes

   - Pregnant or nursing

   - Non-English speaker

   - Claustrophobic

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sunyoung Park, BA